Featured Articles


Assessment of Drug Sensitivity in Hematopoietic Stem and Progenitor Cells From Acute Myelogenous Leukemia and Myelodysplastic Syndrome Ex Vivo

Despite the fact that malignant hematopoietic stem and progenitor cells play critical roles in the initiation, maintenance, and progression of acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS), information about the effects of investigational chemotherapeutic agents on these cells is limited. Using the Nedd8-activating enzyme inhibitor MLN4924 as an example, the authors describe a method for examining the impact of novel chemotherapeutics on these populations ex vivo, demonstrate that MLN4924 is generally more active against AML stem and progenitor cells than the standard-of-care agent cytarabine, and report that MLN4924 is also active against MDS stem and progenitor cells ex vivo.



Concise Review: Organ Engineering: Design, Technology, and Integration

Organ engineering offers tremendous promise for regenerative medicine on multiple fronts, including transplants for patients and improved preclinincal diagnostic modeling. This review encompasses integrative approaches in engineering in an accessible manner. In addition to its core subject, improved culture systems are discussed which could benefit biologists across fields, not just stem cell biology and regenerative medicine.

 

Journal Club Discussions

November 13, 2016

A new study in a myocardial infarction mouse model demonstrates how a novel reprogramming approach may permit enhanced cardiosphere-based myocardial regeneration

Comment

Discuss

Article Scans

December 5, 2016
A gamma-secretase inhibitor treatment of iPSC-derived cells inhibits tumorigenicity and may allow for safer iPSC-based therapeutics
December 5, 2016
A new study demonstrates the successful application of iPSC-derived oligodendrocyte precursor cells in a marmoset model of multiple sclerosis
November 27, 2016
New research demonstrates that mesenchymal stem cells derived from induced pluripotent stem cells are effective in the repair of bone defects

Video Summary

Video abstract from Drs. Barnawi, Al-Khaldi, Sleiman, Sarkar, Al-Dhfyan, Al-Mohanna, Ghebeh, and Al-Alwan on their recently published STEM CELLS paper entitled, "Fascin is Critical for the Maintenance of Breast Cancer Stem Cell Pool Predominantly via the Activation of the Notch Self-Renewal Pathway" Read the Paper here.

Video abstract from Dr. Allen on his recently published STEM CELLS paper entitled, "Angiopellosis as an Alternative Mechanism of Cell Extravasation" Read the Paper here.

Video abstract from Drs. Serena, Keiran, Ceperuelo-Mallafre, Ejarque, Fradera, Roche, Nuñez-Roa, Vendrell, and Férnandez-Veledo on their recently published STEM CELLS paper entitled, "Obesity and Type 2 Diabetes Alters the Immune Properties of Human Adipose Derived Stem Cells" Read the Paper here.

Graphical Abstracts

Confocal picture showing the myelinogenic potential of hiPS-NSCs engrafted at the border between the striatum and the corpus callosum of immunodeficient MLD mice at 3 months post-transplantation(green, human cells labeled with anti-human mitochondria; red, myelin basic protein; blue, nuclei counterstained with ToPro3). Scale bar: 100µm.

An ex vivo culture system used to isolate scalable quantities of hS/PCs with consistent expression of progenitor markers, is reported here. These hS/PCs can be maintained in long-term culture in 2D or in 3D, without loss of stem/progenitor markers.  Incorporation of bioactive basement membrane-derived peptides in the 3D hyaluronate (HA) hydrogel culture system enhances progenitor expansion.  Stimulation of hS/PC spheroids with neurotransmitter agonists leads to differentiation toward an acinar lineage.

Stem cells are emerging as a scientifically plausible treatment and possible cure for cerebral palsy, but are not yet proven. The lack of valid animal models has significantly hampered the scope of clinical trials. Despite the state of current treatment evidence, parents remain optimistic about the potential improvements from stem cell intervention and feel compelled to exhaust all therapeutic options, including stem cell tourism. Receiving unproven therapies from unvalidated sources is potentially dangerous. Thus it is essential that researchers and clinicians stay up to date. A systematic review and meta-analysis summarizing and aggregating current research data may provide more conclusive evidence to inform treatment decision making and help direct future research.